FAP

FAP-PI3KI1 is a fibroblast-activated protein (FAP) inhibitor that selectively targets the phosphoinositide 3-kinase (PI3K) pathway in FAP-expressing human cells. This compound effectively inhibits collagen synthesis and reduces collagen deposition, making it a valuable tool for research in idiopathic pulmonary fibrosis (IPF) and related fibrotic conditions. Its targeted action facilitates investigating the role of the PI3K signaling pathway in fibrosis and offers potential insights into therapeutic strategies for IPF.

BR102910 is a selective inhibitor of fibroblast activation protein (FAP) with an IC50 of 2 nM. Additionally, BR102910 exhibits inhibition of prolyl oligopeptidase (PREP) with an IC50 of 49.00 μM. This compound is primarily used in research focusing on type 2 diabetes and related metabolic disorders, making it a valuable tool for exploring FAP's role in these conditions.

FAP Ligand 1 is a high-affinity small-molecule ligand that selectively targets fibroblast activation protein (FAP). This reagent is designed for conjugation with therapeutic agents, facilitating targeted delivery to FAP-expressing fibroblasts in cancer research. FAP Ligand 1 also has applications in radiation imaging studies, enhancing the visualization of tumors that express this biomarker.

L-Proline 4-methoxy-β-naphthylamide hydrochloride primarily targets FAP (Fibroblast Activation Protein) and serves as a potential anti-tumor agent. This compound is utilized in the preparation of FAP-activated anti-tumor compounds, making it relevant in cancer research and therapeutic development. Its unique chemical structure contributes to the exploration of novel strategies for targeting tumor microenvironments.

NOTA-FAPI-52 is a tumor uptake tracer that targets fibroblast activation protein (FAP). This compound can be radiolabeled for use in positron emission tomography (PET) imaging and other bioimaging methods. NOTA-FAPI-52 is particularly useful in studying diseases characterized by the overexpression of FAP, aiding in the understanding of various tumor environments and potential therapeutic interventions.

Ac-Gly-Pro-AFC is a fluorogenic substrate specifically designed to assess fibroblast activation protein (FAP) endopeptidase activity. This compound exhibits high sensitivity and selectivity, making it useful for studying FAP's role in tumor microenvironments and fibrosis. It is applicable in various research domains, including cancer biology and tissue remodeling studies, facilitating the quantification of enzymatic activity in biological samples.

SID 125240931 is a modulator of fluorogen activating proteins (FAPs), primarily targeting the interaction between fluorogens and FAP. This compound is designed to disrupt binding affinity, providing insights into FAP-mediated processes. It has potential applications in cellular imaging and monitoring protein interactions, making it a valuable tool for researchers in cell biology and molecular imaging studies.